Antex Biologics Inc.
300 Professional Drive
Gaithersburg,
MD 20879
United States - Map
Phone: 301-590-0129
Fax: 301-590-0731
Web Site: http://www.antexbiologics.com
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 36 |
|
| Antex Biologics, Inc., a development stage company, through its wholly owned subsidiary, Antex Pharma, Inc., engages in the research and development of bacterial vaccines and novel antibiotics. The company has developed three platform technologies: Antigen Receptor Technology (ART), Nutriment Signal Transduction (NST), and Virulence Expression Profiling (VEP). ART and NST enable to discover disease-specific proteins. VEP platform uses functional genomics to profile and identify disease-specific proteins. The company is conducting research and development activities, including discovery, and preclinical analysis and trials with respect to various biopharmaceutical products, including prophylactic and therapeutic vaccines and antibiotics for bacterial infections. It has strategic alliances with GlaxoSmithKline, Aventis Pasteur, and the U.S. Department of Defense. Antex Biologics was founded in 1988 and is based in Gaithersburg, Maryland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. V. M. Esposito Ph.D., 68
Chairman, Chief Exec. Officer and Pres |
$
400.00K |
$
0 | Mr. Kyle W. Keese , 47
VP - Bus. Devel. |
$
137.00K |
$
0 | Dr. W. James Jackson Ph.D., 54
VP - Research |
$
143.00K |
$
0 | Dr. Alan Liss Ph.D., 61
VP - Product Devel. |
$
109.00K |
$
0 | Mr. Jeffrey V. Pirone , 48
Chief Financial Officer, Principal Accounting Officer, Exec. VP, Sec. and Treasurer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-01
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.63% Nasdaq 
0.03%
Profile
